APAC Healthcare Weekly (Jan 12)- Wuxi Biologics, Astellas, Otsuka, Samsung Biologics, Pharmaessentia
APAC healthcare companies got approvals for new products as well as clinical trials. The companies continued with acquisitions and collaborations...
590 Views
APAC Healthcare Weekly (Oct 6)-Strong Yen Impact, Sigma's Remedial Measures, Mesoblast's Fund Raise
BoJ interest rate hike leads to Yen appreciation, potentially impacting export-oriented healthcare industry. Sigma Healthcare addresses anti...
462 Views
Hogy Medical (3593) | New Strategy Sparks Investor Confidence
Dalton & Co. shows confidence in Hogy Medical's new plan to boost ROE, revenue, and shareholder returns, potentially unlocking significant...
490 Views
Consolidation in the Med-Tech Sector? Eiken and Hogy to Benefit
The med-tech sector is ripe for consolidation. Smaller players like Hogy Medical (3593 JP) , and Eiken Chemical (4549 JP) exhibit sub-par growth...
492 Views
Hogy Medical (3593): A Prescription for Renewed Growth
NAVF and Dalton invest in Hogy Medical for market dominance in disposable surgical equipment, signaling aggressive overseas expansion and...
487 Views